Get MindMed Updates:
Get MindMed Updates:
Press Release
MindMed Launches Study of Low-Dose LSD Effects on Sleep and Cognitive Measures
11/16/2021
Press Release
MindMed Announces Financial Results for the Third Quarter 2021 and Business Highlights; Cash Balance of $145.9 USD ($185.4 CAD) to Execute on Diverse Clinical Pipeline
11/15/2021
Press Release
MindMed to Present at the Jefferies London Healthcare Conference
11/12/2021
Investor Presentation
Quarterly Corporate Update
Corporate Update Q&A
Regulation of Human Research with LSD in The United States
Q3 2021 Earnings Call Recording
Q2 2021 Management's Discussion and Analysis
Q2 2021 Consolidated Financial Statements
Q1 2021 Management's Discussion and Analysis
Q1 2021 Consolidated Financial Statements
2020 Audited Annual Consolidated Financial Statements
Year-end 2020 Management's Discussion and Analysis
Q3 2020 Management's Discussion and Analysis
Q3 2020 Consolidated Financial Statements
Q2 2020 Management's Discussion and Analysis
Q2 2020 Consolidated Financial Statements
Q2 2020 Earnings Call Recording
2019 Audited Annual Consolidated Financial Statements
Year-end 2019 Management's Discussion and Analysis
Year-end 2019 Earnings Call & Corporate Update
MindMed Sedar Profile
Audit Committee Charter
Compensation Nomination and Governance Charter
Insider Trading Policy
Majority Voting Policy
Policy RE Diversity of Executive Officers
Policy RE Diversity on Board
Privacy Policy
Policy RE Anti-Money Laundering and Anti-Terrorist Financing
Board of Directors Charter
Anti-Bribery and Anti-Corruption Policy
Nasdaq Statement of Governance Differences
